Samsung Biologics raises 2026 revenue forecast to $4.1bn

Samsung Biologics Co. raised its 2026 revenue forecast by 148.4 billion won ($111.9 million) to 5.47 trillion won, up 20 percent from last year, citing full utilization of Plants…

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (pulse.mk.co.kr)